Musings from The Power List: Ali Tavassoli
Ali Tavassoli explains how cyclic peptides and new discovery tools are opening up once-inaccessible biology
False
Ali Tavassoli explains how cyclic peptides and new discovery tools are opening up once-inaccessible biology
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
October 12, 2026
8 min read
SOTIO Biotech’s CSO explains why drug developers should test their weakest assumptions early, how she builds innovative teams, and where ADCs could go next
October 8, 2026
4 min read
We asked the 2026 Power List whether newer modalities have eclipsed small molecules – and where the traditional mainstay still wins
October 5, 2026
4 min read
Regeneron's L. Andres Sirulnik explains why modernizing clinical trials is as important as developing new medicines
October 2, 2026
5 min read
We asked the 2026 Power List how the pharmaceutical industry can prepare for geopolitical, economic, regulatory, and scientific uncertainty
False
Affiliations:
Specialties:
Areas of Expertise: